US4402948A - Steroid glycoside compounds and methods of use - Google Patents

Steroid glycoside compounds and methods of use Download PDF

Info

Publication number
US4402948A
US4402948A US06/227,764 US22776481A US4402948A US 4402948 A US4402948 A US 4402948A US 22776481 A US22776481 A US 22776481A US 4402948 A US4402948 A US 4402948A
Authority
US
United States
Prior art keywords
ethyl
methylpentyl
acetyl
compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US06/227,764
Other languages
English (en)
Inventor
Shingo Matsumura
Hiroshi Enomoto
Koji Kitaguchi
Masakuni Ozaki
Masahiko Kitano
Toshihiro Okamura
Haruo Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Assigned to NIPPON SHINYAKU CO., LTD., reassignment NIPPON SHINYAKU CO., LTD., ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: ENOMOTO HIROSHI, KITAGUCHI KOJI, KITANO MASAHIKO, MATSUMURA SHINGO, OKAMURA TOSHIHIRO, OZAKI MASAKUNI, TANAKA HARUO
Application granted granted Critical
Publication of US4402948A publication Critical patent/US4402948A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Definitions

  • Table 1 Examples of the compounds according to the present invention are shown in Table 1. A process for the preparation of them is shown in Table 2. Their acute toxicity and hemostatic and capillary stabilizing effects are shown in Tables 3-5.
  • Thy can be synthesized easily by condensing cholesterol, ⁇ -sitosterol and stigmasterol, respectively, with 1-bromo-1-deoxy-2,3,4,6-tetraacetyl- ⁇ -D-glucopyranose according to Konigs-Knorr method.
  • compounds (5), (6) and (7) can be reduced with sodium borohydride into compounds (11), (12) and (13), respectively. Those compounds can further be hydrolyzed by a proper method into compounds (14), (15) and (16) and other partial hydrolyzates.
  • LD 50 values of oxidized derivatives of steryl- ⁇ -D-glucoside and acetyl derivatives thereof were calculated by Litchfield-Wilcoxon method using male mice.
  • mice each comprising 10 male mice were employed. According to a method of Motohashi, et al. [Journal of Tokyo Jikei-kai Medical College, 75 (5) (1959)], the end of tail (1 cm) of each mouse was cut out with a sharp surgical knife and the blood threading from the wound into water was observed. A time required until the bleeding stopped completely was measured and rate of readuction of the bleeding time as compared with that of untreated control group was calculated.
  • the oxidized sterylglycoside derivatives of the present invention have remarkable hemostatic and capillary stabilizing effects, they exhibit powerful hemostatic effects on the bleeding caused by various factors and they act specifically on the capillary membranes to show capillary-stabilizing and -protective effects even in a very small amount. Therefore, those derivatives can be used as hemostatic agents of quite low toxicity which are effective on bleeding due to various causes or as long lasting capillary-stabilizing remedies for functional disorders in peripheral blood vessels caused by an increase in capillary permeability due to weakened blood vessels.
  • Those compounds can be used in the form of an injection or intraoral drug (solid). For example, they are used as follows:
  • Distilled water for injection is added to the above compounds to make the total quantity 100 ml.
  • the injection is used one to several times a day each in a dose of 2-10 ml.
  • Distilled water for injection is added to the above compounds to make the total quantity 100 ml.
  • the injection is used one to several times a day each in a dose of 1-10 ml.
  • 300 mg-l g/day is taken several times a day.

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
US06/227,764 1980-02-08 1981-01-23 Steroid glycoside compounds and methods of use Expired - Fee Related US4402948A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1530880A JPS56113799A (en) 1980-02-08 1980-02-08 Glucoside derivative
JP55-15308 1980-02-08

Publications (1)

Publication Number Publication Date
US4402948A true US4402948A (en) 1983-09-06

Family

ID=11885160

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/227,764 Expired - Fee Related US4402948A (en) 1980-02-08 1981-01-23 Steroid glycoside compounds and methods of use

Country Status (7)

Country Link
US (1) US4402948A (enExample)
JP (1) JPS56113799A (enExample)
CH (1) CH644133A5 (enExample)
DE (1) DE3104019A1 (enExample)
FR (1) FR2475556A1 (enExample)
GB (1) GB2068964B (enExample)
IT (1) IT1170692B (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552868A (en) * 1982-08-20 1985-11-12 Etablissements Nativelle S.A. 14-Amino steroid derivatives, a process for the preparation thereof and method of use thereof
AU575783B2 (en) * 1982-08-20 1988-08-11 Etablissements Nativelle S.A. 14-amino steroid derivatives
US5168681A (en) * 1990-08-20 1992-12-08 Horsel Plc Prestressed wood floor system
US5278296A (en) * 1990-01-23 1994-01-11 Gelman Sciences Inc. Production of hydroxysteryl glycoside compounds
US5496806A (en) * 1990-01-23 1996-03-05 R. Erich Klemke Glycoside compounds and production and use thereof
US5693767A (en) * 1991-01-22 1997-12-02 Harrier Inc. Glycoside derivatives of acetaminophen

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083969A (en) * 1975-04-08 1978-04-11 Nippon Shinyaku Co., Ltd. Process for preparing easily absorbable sterol glycoside
US4157894A (en) * 1976-06-03 1979-06-12 Inverni Della Beffa S.P.A. Production and analysis of ginseng root extract
US4188379A (en) * 1976-12-30 1980-02-12 Roecar Holdings (Netherlands Antilles) N.V. Sterolins and their use
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
US4333926A (en) * 1975-05-22 1982-06-08 Nippon Shinyaku Co., Ltd. Steryl-β-D-glucoside pharmaceutical compositions and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2312257A1 (fr) * 1975-05-28 1976-12-24 Nippon Shinyaku Co Ltd Produits pharmaceutiques a action hemostatique comprenant des steryl-b-d-glucosides et leurs monopalmitates
DE2708666C3 (de) * 1977-02-28 1979-12-20 The Green Cross Corp., Osaka (Japan) Arzneimittel mit immunoregulativer und antiphlogistischer Wirkung

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083969A (en) * 1975-04-08 1978-04-11 Nippon Shinyaku Co., Ltd. Process for preparing easily absorbable sterol glycoside
US4333926A (en) * 1975-05-22 1982-06-08 Nippon Shinyaku Co., Ltd. Steryl-β-D-glucoside pharmaceutical compositions and use
US4157894A (en) * 1976-06-03 1979-06-12 Inverni Della Beffa S.P.A. Production and analysis of ginseng root extract
US4188379A (en) * 1976-12-30 1980-02-12 Roecar Holdings (Netherlands Antilles) N.V. Sterolins and their use
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552868A (en) * 1982-08-20 1985-11-12 Etablissements Nativelle S.A. 14-Amino steroid derivatives, a process for the preparation thereof and method of use thereof
AU575783B2 (en) * 1982-08-20 1988-08-11 Etablissements Nativelle S.A. 14-amino steroid derivatives
US5278296A (en) * 1990-01-23 1994-01-11 Gelman Sciences Inc. Production of hydroxysteryl glycoside compounds
US5496806A (en) * 1990-01-23 1996-03-05 R. Erich Klemke Glycoside compounds and production and use thereof
US5168681A (en) * 1990-08-20 1992-12-08 Horsel Plc Prestressed wood floor system
US5693767A (en) * 1991-01-22 1997-12-02 Harrier Inc. Glycoside derivatives of acetaminophen
US6093805A (en) * 1991-01-22 2000-07-25 The Regents Of The University Of Michigan Glycoside compounds and methods of synthesis

Also Published As

Publication number Publication date
JPS56113799A (en) 1981-09-07
FR2475556B1 (enExample) 1983-07-18
FR2475556A1 (fr) 1981-08-14
GB2068964A (en) 1981-08-19
DE3104019A1 (de) 1981-12-17
IT1170692B (it) 1987-06-03
CH644133A5 (de) 1984-07-13
IT8147724A0 (it) 1981-02-04
GB2068964B (en) 1984-09-26

Similar Documents

Publication Publication Date Title
US5276058A (en) 3,4-dihydroxychalcone derivatives
Linardi et al. Lapachol derivative active against mouse lymphocytic leukemia P-388
DE3124780C2 (enExample)
US4818441A (en) Quinine derivatines
DE2858726C2 (de) Arzneimittel zur senkung des serumcholesterinspiegels
DE3124719C2 (de) 10-(1,2-Propadienyl)-östr-4-en-3,17-dion, entsprechendes Zwischenprodukt und pharmazeutische Zubereitungen, die diese Verbindungen enthalten
US4073935A (en) Substituted propanol-(2)-derivatives and their nicotinic acid esters, and process for their preparation, and the use thereof as hypolipemic drugs
US4885280A (en) Novel 14-amino steroids
DE2923368A1 (de) Neue 5-fluor-( beta -uridin oder 2'-desoxy- beta -uridin)-derivate, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
US4402948A (en) Steroid glycoside compounds and methods of use
DE2821403C2 (de) Decahydronaphthalin-1-spiro-2'-dihydrobenzofurane, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
US4617292A (en) Pharmaceutical compositions and method for inhibiting histamine release tocopheryl glycoside
DE3049959C2 (enExample)
JP2782117B2 (ja) リン脂質誘導体
EP0121806B1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
DE3632893A1 (de) 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
US3546250A (en) 6-hydroxy-7-methoxy flavane derivatives and esters thereof
DE2640294A1 (de) Furanose-o-pyridylcarbonsaeureester
US4560703A (en) Clavulone derivatives, process for preparing the same, and use of said compounds
KR830002842B1 (ko) 글리코사이드 유도체의 제조방법
US6071898A (en) Asiatic acid derivatives having modified A-ring
US4189489A (en) 5-Alkoxy-picolinic acid calcium salts and anti-hypertensive composition containing 5-alkoxy-picolinic acid calcium salts and anti-hypertensive composition thereof
CH503015A (de) Verfahren zur Herstellung von 1,4-Benzodioxanderivaten
US4436735A (en) Ketals of 3'"-dehydrocardenolide tridigitoxosides
CH638817A5 (de) Nicht-glykosidische theophyllin-zucker-derivate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 19870906